Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
5.44
-0.04 (-0.73%)
At close: Feb 20, 2026, 4:00 PM EST
5.52
+0.08 (1.47%)
After-hours: Feb 20, 2026, 7:25 PM EST
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.87 billion as of February 20, 2026. Its market cap has increased by 126.18% in one year.
Market Cap
1.87B
Enterprise Value
1.37B
1-Year Change
126.18%
Ranking
Category
Stock Price
$5.44
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.87B, an increase of 968.91%. That is a compound annual growth rate of 53.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.87B | -39.29% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sarepta Therapeutics | 1.98B |
| Stoke Therapeutics | 1.96B |
| Vericel | 1.93B |
| Aurinia Pharmaceuticals | 1.90B |
| Olema Pharmaceuticals | 1.89B |
| Pharvaris | 1.82B |
| Galecto | 1.82B |
| RAPT Therapeutics | 1.79B |